## Policy Analysis Report: Amendments to the Narcotic Drugs and Psychotropic Substances Act, 1985
**1. Executive Summary:**
This report analyzes two notifications issued by the Ministry of Finance, Department of Revenue, Government of India, both dated April 16, 2025, pertaining to the Narcotic Drugs and Psychotropic Substances Act, 1985. The first notification (S.O. 1729E) declares Butonitazene as a manufactured drug. The second notification (S.O. 1731E) amends a previous notification (S.O. 1055 E, dated October 19, 2001) by adding several new psychotropic substances to the Schedule of the Act, including 3-Chloromethcathinone (3-CMC), Dipentylone, 2-Fluorodeschloroketamine, and Bromazolam, and specifies their small commercial quantities and single dose quantities. These amendments aim to update the list of controlled substances to address emerging drug trends and align with international conventions.
**2. Introduction:**
This report provides an informative analysis of two recent notifications related to the Narcotic Drugs and Psychotropic Substances Act, 1985, based solely on the content of the provided government policy text. The report details the policy changes and their implications as derived from the official documentation.
**3. Policy Overview:**
* This report analyzes two amendments to the Narcotic Drugs and Psychotropic Substances Act, 1985. One is a new declaration, and the other is an amendment to S.O. 1055 E, dated October 19, 2001.
* **Core Objective(s):** Based on the text, the core objectives of these changes are to:
* Update the list of substances controlled under the Act to include newly identified or emerging narcotic and psychotropic substances.
* Specify the "small quantity" and "commercial quantity" for newly added substances, presumably to aid in law enforcement and judicial processes related to drug offenses.
**4. Background and Rationale:**
* The declaration of Butonitazene as a manufactured drug suggests its emergence as a substance of abuse that warrants control under the Narcotic Drugs and Psychotropic Substances Act, 1985.
* The likely reason for the second amendment, the addition of new psychotropic substances, is to address the increasing availability and abuse of these substances. The notification explicitly states it is based on information and evidence regarding the "nature and effect of and the scope for abuse" of these substances and to incorporate changes from the "United Nations Convention on Psychotropic Substances, 1971". The addition of new substances and specification of quantities demonstrates an effort to stay current with drug trends and international regulations.
**5. Key Provisions / Changes:**
This section details the key changes introduced by the notifications:
* **Notification S.O. 1729E:** Declares Butonitazene (N, N-Diethyl-2-(4-butoxyphenylmethyl)-5-nitro-1H-benzimidazole-1-ethanamine) as a manufactured drug under the Narcotic Drugs and Psychotropic Substances Act, 1985.
* **Notification S.O. 1731E:** Amends notification S.O. 1055 E, dated October 19, 2001, by inserting the following new substances into the Schedule of the Act along with their respective "small quantity" and "commercial quantity":
| S. No. | Name of Narcotic Drug and Psychotropic Substance | Other non-proprietary names | Chemical name | Small Quantity in gm. | Commercial Quantity in gm. |
| ------- | ------------------------------------------------ | --------------------------- | ---------------------------------------------------------- | --------------------- | -------------------------- |
| 238ZZZH | Butonitazene | | N,N-Diethyl-2-(4-butoxyphenylmethyl)-5-nitro-1H-benzimidazole-1-ethanamine | 5 | 250 |
| 238ZZZI | 3-Chloromethcathinone | 3-CMC | 1-(3-chlorophenyl)-2-(methylamino)propan-1-one | 5 | 250 |
| 238ZZZJ | Dipentylone | | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one | 2 | 100 |
| 238ZZZK | 2-Fluorodeschloroketamine | | 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one | 5 | 250 |
| 238ZZZL | Bromazolam | | Bromo-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine | 0.1 | 5 |
**Impact of the Changes:** These changes bring Butonitazene, 3-CMC, Dipentylone, 2-Fluorodeschloroketamine, and Bromazolam under the purview of the Narcotic Drugs and Psychotropic Substances Act, 1985. The "small quantity" and "commercial quantity" designations will be used to determine the severity of penalties for offenses involving these substances.
**6. Target Audience and Stakeholders:**
Based on the provided text, the primary target audience and stakeholders affected by these changes include:
* Law enforcement agencies involved in drug control and investigation.
* The judiciary, particularly courts handling cases related to drug offenses.
* Pharmaceutical companies and chemical manufacturers who may handle these substances (legitimately or illegitimately).
* Individuals who use or traffic in these controlled substances.
* Healthcare professionals involved in treating substance abuse.
**7. Implementation Aspects (Inferred):**
* **Responsible Agency/Bodies:** The Ministry of Finance (Department of Revenue) is the responsible body for issuing these notifications. Law enforcement agencies at the central and state levels are responsible for implementing the provisions of the Act.
* **Timelines/Procedures:** The notifications are effective from the date of publication (April 16, 2025). The text does not specify any particular procedures, but it is inferred that law enforcement and judicial processes will be updated to reflect the inclusion of these new substances.
* **Amendment Specific Implementation:** Law enforcement and judicial bodies will need to familiarize themselves with the new substances and their designated quantities to effectively enforce the law.
**8. Expected Outcomes / Impact of Changes:**
The likely intended outcomes of these changes are:
* Reduced availability and abuse of Butonitazene, 3-CMC, Dipentylone, 2-Fluorodeschloroketamine, and Bromazolam.
* More effective prosecution of individuals involved in the trafficking and possession of these substances.
* Alignment of national drug control policies with international standards.
* Better tracking and monitoring of these substances.
**9. Conclusion:**
The amendments to the Narcotic Drugs and Psychotropic Substances Act, 1985, through these notifications reflect an ongoing effort to address emerging drug trends and strengthen drug control measures in India. By declaring Butonitazene as a manufactured drug and adding 3-CMC, Dipentylone, 2-Fluorodeschloroketamine, and Bromazolam to the list of psychotropic substances, the government aims to protect public health and safety and combat drug trafficking. The specified quantities will likely impact sentencing and enforcement strategies related to these substances.
Key Entities Referenced
Narcotic Drugs and Psychotropic Substances Act, 1985: Act under which the Central Government is exercising its powers to declare substances as manufactured drugs and to amend the list of psychotropic substances.
Ministry of Finance: Government organization issuing the notifications regarding manufactured drugs and psychotropic substances.
Department of Revenue: A department within the Ministry of Finance.
Central Government: The governing body making declarations and amendments related to narcotic drugs and psychotropic substances.
S.O. 1729E: Notification number related to the declaration of Butonitazene as a manufactured drug.
S.O. 1730E: Notification number related to adding substances to the list of psychotropic substances.
S.O. 1731E: Notification number related to amendments regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
United Nations Convention on Psychotropic Substances, 1971: An international agreement related to psychotropic substances, influencing the Central Government's actions.
N1201182023NC: File number associated with the notifications.
S.O. 785E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 49E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 39E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 475E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
G.S.R. 621E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
G.S.R. 1E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 311 E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 376E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. No. 2374 E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. No. 1383 E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 821E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 1761E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 3448E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 1352E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 1275E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 4428E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 5319 E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 578E: Notification number, related to the amendment in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985.
S.O. 1055 E: Notification number related to amendments regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 2941 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 1430 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 375 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 2375E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 384 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 822 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 1762 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 1351 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 1276 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 4429 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
S.O. 5320 E: Notification number, related to the amendment regarding Small Commercial Quantity and Narcotic Drug and Psychotropic Substance.
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
सी.जी.-डी.एल.-अ.-16042025-262467
CG-DxLx-xEG-I1D6H0x4x2x0 25-262467
xxxGIDExxx
असाधारण
EXTRAORDINARY
भाग II—खण् ड 3—उप-खण्ड (ii)
PART II—Section 3—Sub-section (ii)
प्राजधकार स ेप्रकाजित
PUBLISHED BY AUTHORITY
स.ं 1698] नई दिल्ली, बुधिार, अप्रलै 16, 2025/चत्रै 26, 1947
No. 1698] NEW DELHI, WEDNESDAY, APRIL 16, 2025/CHAITRA 26, 1947
जित्त मत्रं ालय
(रािस्ट्ि जिभाग)
अजधसचू ना
नई दिल्ली, 16 अप्रलै , 2025
का.आ. 1729(अ).—स्ट्िापक औषजध और मन:प्रभािी पिार् थ अजधजनयम, 1985 (1985 का 61) की धारा 2 के
खंड (xi) के उप-खंड (ख) द्वारा प्रित्त िजियों का प्रयोग करत े हुए, केन्द्रीय सरकार जनम्नजलजखत पिार्,थ लिण और उनकी
जनर्मथजतयों को जनर्मथत औषजध घोजषत करती ह,ै अर्ाथत:-
ब्यूटोजनटाजीन : एन , एन -डाइएजर्ल-2-[(4-ब्यूटोक्सीफेजनल)जमर्ाइल]-5-नाइरो-1 एच -बेजन्द्जजमडाजोल-1-
एर्ेनामाइन
[फा. सं. एन-12011/8/2023-एनसी-II]
मुकेि सुंिररयाल, अिर सजचि
2541 GI/2025 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
MINISTRY OF FINANCE
(Department of Revenue)
NOTIFICATION
New Delhi, the 16th April, 2025
S.O. 1729(E).— In exercise of the powers conferred by Sub-clause (b) of clause (xi) of section 2 of the Narcotic
Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby declares the following
substance, salt and preparations thereof to be manufactured drugs, namely:-
Butonitazene : N, N-Diethyl-2-[(4-butoxyphenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine
[F. No. N-12011/8/2023-NC. II]
MUKESH SUNDRIYAL, Under Secy.
अजधसचू ना
नई दिल्ली, 16 अप्रलै , 2025
का.आ. 1730(अ).— चूंदक केंरीय सरकार, जनम्नजलजखत पिार्ों (प्राकृजतक या कृजत्रम) या प्राकृजतक सामग्री या ऐसे
पिार्ों या सामजग्रयों के दकसी लिण या जनर्मथजत की प्रकृजत और प्रभाि तर्ा उनके िरुु पयोग की गुंिाइि और ऐसे पिार्ों के
संबंध म ेंसंिोधन तर्ा मन:प्रभािी पिार्ों पर संयुि राष्ट्र कन्द्ििें न, 1971 म ेंसजममजलत दकए गए पररितथनों के संबंध म,ें उस े
उपलब्ध हुई सूचना और साक्ष्य के आधार पर संतुष्ट ह ै दक जनम्नजलजखत पिार्ों या प्राकृजतक सामजग्रयों या लिणों या ऐस े
पिार्ों या सामजग्रयों के जनर्मथजत को स्ट्िापक औषजध और मन:प्रभािी पिार्थ अजधजनयम, 1985 (1985 का 61) (जिसे इसम ें
इसके पश्चात ् उि अजधजनयम कहा गया ह)ै की अनुसूची म ें जिजनर्िथष्ट मन:प्रभािी पिार्ों की सचू ी म ें िोड़ना आिश्यक ह;ै
अतः अब, उि अजधजनयम की धारा 3 द्वारा प्रित्त िजियों का प्रयोग करते हुए, केन्द्रीय सरकार उि अजधजनयम
की अनुसूची म ें जिजनर्िथष्ट मन:प्रभािी पिार्ों की सूची म ें जनम्नजलजखत और संिोधन करती ह,ै अर्ाथत:् -
उि अजधजनयम की अनुसूची म,ें क्रम संख्या 110ZZE और उससे संबंजधत प्रजिजष्टयों के पश्चात् क्रमिः जनम्नजलजखत
क्रम संख्या और प्रजिजष्टयााँ अंतःस्ट्र्ाजपत की िाएगं ी, अर्ाथत्:-
क्र. स.ं अंतराष्ट्रथ ीय गरै - अन्द्य गैर-स्ट्िाजमत्ि िाले नाम रासायजनक नाम
स्ट्िाजमत्ि िाले नाम
“110ZZF 3-क्लोरोमर्े कैजर्नोन 1-(3-क्लोरोफेजनल)-2-(जमर्ाइलैजमनो) प्रोपेन-
(3-सीएमसी) 1-एक
110ZZG जडपेन्द्टाइलोन 1-(1,3-बेंिोडायऑक्सोल-5-िाईएल)-2-
(डाइजमर्ाइलैजमनो) पेंटन-1-एक
110ZZH 2-फ्लोरोडस्ट्े क्लोरोकेटामाइन 2-(2-फ्लोरोदफनाइल)-2-(मेजर्लैजमनो)
साइक्लोहक्े सन-1-एक)
110ZZI ब्रोमाजोलम ब्रोमो-1-जमर्ाइल-6-फेजनल-4एच-एस-
रायजोलो[4,3- ए ][1,4]बेंजोडायजेपीन
[फा. सं. एन-12011/8/2023-एनसी-II]
मुकेि सुंिररयाल, अिर सजचि[भाग II—खण् ड 3(ii)] भारत का रािपत्र : असाधारण 3
नोट: स्ट्िापक औषजध और मन:प्रभािी पिार् थअजधजनयम, 1985 (1985 का 61) की अनुसूची म ें पहला संिोधन संख्या का.
आ. 785(अ) दिनांक 26 अक्टूबर, 1992 के माध्यम से दकया गया र्ा और इसमें बाि म ेंसंख्या का. आ. 49(अ) दिनांक
8 िनिरी, 1993, का. आ. 39(अ) दिनांक 12 िनिरी , 1996, का. आ. 475(अ) दिनांक 11 िून, 2003, िीएसआर
621(अ) दिनांक 1 अगस्ट्त, 2003, िीएसआर 1(अ) दिनांक 2 िनिरी, 2004, का. आ. 311(अ) दिनांक 10 फरिरी,
2011, का. आ. 376(अ) दिनांक 5 फरिरी, 2015, का. आ. संख्या 2374(अ) दिनांक 12 फरिरी, 2015, िुलाई,
2016, का. आ. संख्या 1383 (अ), दिनांक 2 मई, 2017, का. आ. 821 (अ), दिनाकं 27 फरिरी, 2018,
का. आ. 1761 (अ), दिनांक 26 अप्रलै , 2018 और का. आ. 3448 (अ) दिनांक 13 िलु ाई, 2018, का. आ. 1352
(अ), दिनांक 13 माचथ 2019, का. आ. 1275 (अ), दिनांक 23 माचथ 2021, का. आ. 4428 (अ), दिनांक 22 जसतंबर
2022, का. आ. 5319 (अ), दिनांक 16 निंबर, 2022 और का. आ. 578 (अ), दिनांक 8 फरिरी, 2024 के माध्यम
स े संिोधन दकया गया र्ा।
NOTIFICATION
New Delhi, the 16th April, 2025
S.O. 1730(E).— Whereas the Central Government is satisfied, on the basis of information and evidence which
has become available to it, with respect to the nature and effect of and the scope for abuse of the following substances
(natural or synthetic) or natural material or any salt or preparation of such substances or materials, and the modification
with respect to such substances and the changes that have been incorporated in the United Nations Convention on
Psychotropic Substances, 1971, that it is necessary to add the following substances or natural materials or salts or
preparation of such substances or materials in the list of psychotropic substances specified in the Schedule to the
Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) (hereinafter referred to as the said Act);
Now, therefore, in exercise of the powers conferred by section 3 of the said Act, the Central Government hereby
makes the following further amendments in the list of psychotropic substances specified in the Schedule to the said Act,
namely:-
In the said Act, in the Schedule, after serial number 110ZZE and the entries relating thereto, the following
serial numbers and entries shall respectively be inserted, namely :-
S. No. International non- Other non-proprietary names Chemical name
proprietary names
“110ZZF 3-Chloromethcathinone (3-CMC) 1-(3-chlorophenyl)-2-
(methylamino)propan-1-one
110ZZG Dipentylone 1-(1,3-benzodioxol-5-yl)-2-
(dimethylamino)pentan-1-one
110ZZH 2-Fluorodeschloroketamine 2-(2-fluorophenyl)-2-
(methylamino)cyclohexan-1-one)
110ZZI Bromazolam Bromo-1-methyl-6-phenyl-4H-s-
triazolo[4,3-a][1,4]benzodiazepine
[F. No. N-12011/8/2023-NC. II]
MUKESH SUNDRIYAL, Under Secy.
Note: The Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) was first amended, vide
number S.O. 785(E), dated the 26th October, 1992 and subsequently amended, vide numbers S.O. 49(E), dated
the 8th January, 1993, S.O. 39(E), dated the 12th January, 1996, S.O. 475(E), dated the 11th June, 2003,
G.S.R. 621(E), dated the 1st August, 2003, G.S.R. 1(E), dated the 2nd January, 2004, S.O. 311 (E), dated the
10th February, 2011, S.O. 376(E), dated the 5th February, 2015, S.O. No. 2374 (E), dated the 12th July, 2016,
S.O. No. 1383 (E), dated the 2nd May, 2017, S.O. 821(E), dated the 27th February, 2018, S.O. 1761(E), dated the
26th April, 2018 and S.O. 3448(E) dated the 13th July, 2018, S.O. 1352(E), dated the 13th March 2019,
S.O. 1275(E), dated the 23rd March 2021, S.O. 4428(E), dated the 22nd September 2022, S.O. 5319 (E), dated
the 16th November, 2022 and S.O. 578(E), dated the 8th February, 2024.4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
अजधसचू ना
नई दिल्ली, 16 अप्रलै , 2025
का.आ. 1731(अ).— स्ट्िापक औषजध और मन:प्रभािी पिार् थ अजधजनयम, 1985 (1985 का 61) की धारा 2 के
खंड (viiक) और (xxiiक) द्वारा प्रित्त िजियों का प्रयोग करते हुए, केंर सरकार भारत सरकार, जित्त मंत्रालय, रािस्ट्ि जिभाग
की अजधसूचना, िो भारत के रािपत्र, असाधारण, भाग-II, खडं 3, उप-खंड (ii) म ें संख्या का. आ. 1055 (अ), दिनांक 19
अक्टूबर, 2001 द्वारा प्रकाजित हुई र्ी, म ेंजनम्नजलजखत और सिं ोधन करती ह,ै अर्ाथत:-
उि अजधसूचनाओं म,ें सारणी म,ें क्रम संख्या 238 ZZZG और उसस े संबंजधत प्रजिजष्टयों के पश्चात्, जनम्नजलजखत
क्रम संख्या और प्रजिजष्टयां क्रमिः अतं ःस्ट्र्ाजपत की िाएगं ी, अर्ाथत:-
क्र. स.ं स्ट्िापक औषजध अन्द्य गैर-स्ट्िाजमत्ि रासायजनक नाम अल्प मात्रा िाजणजययक
और मन:प्रभािी िाले नाम (ग्राम म)ें (एकल मात्रा
पिार्थ का नाम खुराक ग्राम x (ग्राम म)ें
(अंतरराष्ट्रीय गरै - (अल्प मात्रा
100 म)ें
स्ट्िाजमत्ि नाम ग्राम x 50 म)ें
(आईएनएन))
“238ZZZH ब्यूटोनीटाजीन एन , एन -डाइएजर्ल-2- 5 ग्राम 250 ग्राम
[(4-ब्यूटोक्सीफेजनल)जमर्ाइल]-5-
नाइरो-1 एच -बेजन्द्जजमडाजोल-1-
एर्ेनामाइन
238ZZZI 3-क्लोरोमर्े कैजर्नोन 1-(3-क्लोरोफेजनल)-2- 5 ग्राम 250 ग्राम
(3-सीएमसी) (जमर्ाइलैजमनो) प्रोपने -1-एक
238ZZZJ जडपेन्द्टाइलोन 1-(1,3-बेंिोडायऑक्सोल-5- 2 ग्राम 100 ग्राम
िाईएल)-2-(डाइजमर्ाइलैजमनो)
पेंटन-1-एक
238ZZZK 2- 2-(2-फ्लोरोदफनाइल)-2- 5 ग्राम 250 ग्राम
फ्लोरोडेस्ट्क्लोरोकेटा (मेजर्लैजमनो)साइक्लोहक्े सन-1-
माइन
एक)
238ZZZL ब्रोमाजोलम ब्रोमो-1-जमर्ाइल-6-फेजनल-4एच- 0.1 ग्राम 5 ग्राम
एस-रायजोलो [4,3- क] [1,4]
बेंजोडायजेपीन
[फा. सं. एन-12011/8/2023-एनसी-II]
मुकेि सुंिररयाल, अिर सजचि
नोट: मूल अजधसूचना भारत के रािपत्र, असाधारण, भाग II, खंड 3, उपखडं (ii) में सख्ं या का. आ. 1055 (अ),
दिनांक 19 अक्टूबर, 2001 द्वारा प्रकाजित की गई र्ी और बाि में इसमें का. आ. 2941 (अ), दिनांक 18 निंबर ,
2009, का. आ. 1430 (अ), दिनांक 21 िून , 2011, का. आ. 375 (अ) दिनांक 5 फरिरी , 2015, का. आ. 2375
(अ), दिनांक 12 िुलाई , 2016, का. आ. 384 (अ), दिनांक 2 मई, 2017, का. आ. 822 (अ), दिनांक 27 फरिरी,
2018, का. आ. 1762 (अ), दिनांक 26 अप्रैल, 2018, का. आ. 1351 (अ), दिनांक 13 माचथ, 2018 द्वारा संिोधन
दकया गया र्ा। 2019, का. आ. 1276 (अ), दिनांक 23 माच थ2021, का. आ. 4429 (अ), दिनांक 22 जसतंबर 2022,
का. आ. 5320 (अ), दिनांक 16 निंबर, 2022 और का. आ. 578 (अ), दिनांक 8 फरिरी, 2024 के माध्यम से बाि
में संिोधन दकया गया।[भाग II—खण् ड 3(ii)] भारत का रािपत्र : असाधारण 5
NOTIFICATION
New Delhi, the 16th April, 2025
S.O. 1731(E).— In exercise of the powers conferred by clause (viia) and (xxiia) of section 2 of the Narcotic
Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby makes the following further
amendments in the notification of the Government of India, Ministry of Finance, Department of Revenue, published in
the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii) vide number S.O. 1055 (E), dated the 19th October,
2001, namely:-
In the said notifications, in the Table, after serial number 238 ZZZG and the entries relating thereto, the
following serial numbers and entries shall respectively be inserted, namely: -
S. No. Name of Other non-proprietary Chemical name Small Commercial
Narcotic names Quantity (in Quantity
Drug and gm.) (Single (in gm.)
Psychotropic dose in gm (Small
Substance X 100) quantity in
(International gm X 50)
non-
proprietary
names
(INN))
“238ZZZH Butonitazene N,N-Diethyl-2- 5gm 250gm
[(4-butoxyphenyl)methyl]-
5-nitro- 1H-
benzimidazole-1-
ethanamine
238ZZZI 3-Chloromethcathinone 1-(3-chlorophenyl)- 5 gm 250gm
(3-CMC) 2-(methylamino)propan-
1-one
238ZZZJ Dipentylone 1-(1,3-benzodioxol-5-yl)- 2 gm 100 gm
2-(dimethylamino)pentan-
1-one
238ZZZK 2- 2-(2-fluorophenyl)-2- 5 gm 250 gm
Fluorodeschloroketamine (methylamino)cyclohexan-
1-one)
238ZZZL Bromazolam Bromo-1-methyl-6- 0.1 gm 5 gm
phenyl-4H-s-triazolo[4,3-
a][1,4]benzodiazepine
[F. No. N-12011/8/2023-NC. II]
MUKESH SUNDRIYAL, Under Secy.
Note: The principal notification was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section
(ii), vide number S.O. 1055 (E), dated the 19th October, 2001 and subsequently amended vide numbers
S.O. 2941 (E), dated the 18th November, 2009, S.O. 1430 (E), dated the 21st June, 2011, S.O. 375 (E) dated the
5th February, 2015, S.O. 2375(E), dated the 12th July, 2016, S.O. 384 (E), dated the 2nd May, 2017, S.O. 822(E),
dated the 27th February, 2018, S.O. 1762(E), dated the 26th April, 2018, S.O. 1351 (E), dated the 13th March
2019, S.O. 1276 (E), dated the 23rd March 2021, S.O. 4429 (E), dated the 22nd September 2022, S.O. 5320 (E),
dated 16th November, 2022 and S.O. 578(E), dated the 8th February, 2024.
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.